Shai Mulinari
Biographic Data
| ID | 284740 |
|---|---|
| NAME | Shai Mulinari |
| GIVEN NAMES | Shai |
| FAMILY NAME | Mulinari |
| SIGNATURE | MULINARI S |
| AFFILIATIONS | Lund University |
| ORCID | 0000-0001-8773-9796 |
| VERIFIED | Yes |
| TOTAL WORKS | 29 |
| TOTAL CITATIONS | 45 |
| AUTHOR COUNT | 29 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 3 |
Over-represented as volunteers, under-represented as patients: Racial and ethnic inequalities in a large sample of U.S. phase 1 clinical trials
The dominant narrative on equity, diversity, and inclusion in U.S. medical research emphasises the underrepresentation of Black and Hispanic participants in clinical trials, largely based on therapeutic phase 2 and 3 trials. Far less attention has been paid to phase 1 trials—particularly those involving healthy volunteers who assume health risks without therapeutic benefit, often for money. Focusing on inequalities in the distribution of research…
Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation
Current scholarship on race in Europe has described race as an “absent presence”. However, little is known about the dynamics of the absentness and presentness of race, including how various social processes operating at distinct levels (e.g. supranational and national) influence the uses of race and ethnicity concepts. We begin addressing this gap by examining racialised pharmaceutical regulation in the EU and its operationalisation in European …
Patterns of company misconduct, recidivism, and complaint resolution delays: A temporal analysis of UK pharmaceutical industry self‐regulation within the European context
Interfirm self‐regulation through trade associations is common but its effectiveness is debated and likely varies by time, country, and industry. This study examines self‐regulation of pharmaceutical marketing, characterized by delegation of major regulatory responsibilities to trade associations' self‐regulatory bodies. In addressing critical research gaps, this study first analyzes 1,776 complaints against pharmaceutical companies in the UK ove…
Race in clinical trials in Sweden: How regulatory and medical standards in clinical research trump the post-racial discourse
The post-racial discourse that permeates many Western European countries depicts society as having moved beyond race concepts and classifications. This article focuses on Sweden, a country that, in line with the post-racial thinking, declares race to be an offensive and unscientific concept. The article investigates what happens when this post-racial discourse meets clinical research standards that encourage, if not demand, the collection of data…
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: Implications for self-regulation, public regulation, and transparency
BACKGROUND: Self-regulation of payment disclosure by pharmaceutical industry trade groups is a major global approach to increasing transparency of financial relationships between drug companies and healthcare professionals and organisations. Nevertheless, little is known about the relative strengths and weaknesses of self-regulation across countries, especially beyond Europe. To address this gap in research and stimulate international policy lear…
Short-circuiting biology: Digital phenotypes, digital biomarkers, and shifting gazes in psychiatry
Digital phenotyping is a rapidly growing research field promising to transform how psychiatry measures, classifies, predicts, and explains human behavior. This article advances the social-scientific examination of digital phenotyping's epistemology and knowledge claims. Drawing on the notion of a "neuromolecular gaze" in psychiatry since the 1960s, it suggests that digital phenotyping concerns a new psychiatric gaze-the "digital gaze." Rather tha…
Conceptual unclarity about Covid-19 ethnic disparities in Sweden: Implications for public health policy
The COVID-19 pandemic has shed light on abundant racial and ethnic health disparities in many countries around the world. In Sweden, statistics on COVID-19 mortality and morbidity from both the first and the second wave of the pandemic show that foreign-born individuals have been disproportionately affected, compared to Swedish-born individuals. However, as demonstrated in this article, key stakeholders including politicians, public authorities, …
Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
Pharmaceutical industry funding of patient organizations raises ethical challenges related to patient engagement in healthcare due to fears of commercial agendas influencing patient advocacy and creating industry-driven inequalities across patient organizations. We contribute to an international body of knowledge on patient organization-industry relations by analyzing all payments reported by companies in Denmark over a six-year period, 2014-2019…
The making of a Swedish strategy: How organizational culture shaped the Public Health Agency's pandemic response
Several suggestions have been made as to why Sweden's approach to managing the COVID-19 pandemic came to rely on a strategy based on voluntary measures. Two of the most prominent explanations for why the country chose a different strategy than many other countries have focused on micro- and macro-level factors, explaining the strategy either in terms of the psychologies of prominent actors or by pointing to particularities in Swedish constitution…
Capitalizing on transparency: Commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act
How corporations surveil and influence consumers using big data tools is a major area of research and public debate. However, few studies explore it in relation to physicians in the USA, even though they have been surveilled and targeted by the pharmaceutical industry since at least the 1950s. Indeed, in 2010, concerns about the pharmaceutical industry's undue influence led to the passing of the Physician Sunshine Act, a unique piece of transpare…
Pharmaceutical industry self-regulation and non-transparency: Country and company level analysis of payments to healthcare professionals in seven European countries
The European pharmaceutical industry uses the alleged efficacy of self-regulation to question the need for transparency laws similar to the US Physician Payment Sunshine Act. We conducted a comparative analysis of 20 large companies' payment disclosures in seven European countries in 2017-2019. The data was extracted as part of eurosfordocs.eu, a novel transparency project that scrapes and integrates publicly available databases and disclosures. …
Sociologisk forskning om covid-19-pandemin: En introduktion
En pandemi är en kris och som sådan en ny situation som präglas av både vetenskapliga och samhälleliga osäkerheter, i vilken vardagslivets invanda rutiner till viss del omkullkastas. Covid-19-pandemin har synliggjort redan etablerade samhällsstrukturer och ojämlikheter men också förvärrat maktrelationer och utsatthet. I denna artikel introducerar vi bidragen i Sociologisk Forsknings temanummer om hur samhället och människors liv har påverkats av …
Is there evidence for the racialization of pharmaceutical regulation? Systematic comparison of new drugs approved over five years in the USA and the EU
Recent decades have seen much interest in racial and ethnic differences in drug response. The most emblematic example is the heart drug BiDil, approved by the US Food and Drug Administration in 2005 for "self-identified blacks." Previous social science research has explored this "racialization of pharmaceutical regulation" in the USA, and discussed its implications for the "pharmaceuticalization of race" in terms of reinforcing certain taxonomic …
Sociologiska perspektiv på coronakrisen: Fyra sociologer om samhällets reaktion på covid-19
Sociologisk Forskning bad fyra sociologer i Sverige att svara på några korta frågor om coronapandemin och vårt samhälles hantering av den. Deras tidigare forskning har på olika sätt berört olika frågor såsom socialmedicin och medicinsk kunskapsproduktion, sociala nätverks betydelse för smittspridning, samhällets hantering av kriser och risker, genusaspekter av samhällskriser samt dynamiken mellan expertis, politiker och medborgare i beslutsfattan…
Pharmaceutical lobbying and pandemic stockpiling: A feeling of déjà vu in the Nordic countries and why the sociological perspective is crucial to understand Covid-19
The novel coronavirus SARS-CoV-2 (COVID-19) has spread globally in a short period of time and quickly developed into a pandemic. In connection with its progress, entire cities and countries have been closed down, people are quarantined, and infrastructure and trade have been suspended. As this is a new virus, no vaccine or antiviral drugs are available, but instead non-medical measures such as social distancing may be used to reduce the spread. T…
Revisiting the pharmaceuticalisation of pandemic influenza using Lukes' framework of power
The power of social actors to drive or block pharmaceutical uptake has been a concern in sociological debates on pharmaceuticalisation, including in the case of pandemic vaccination. We build on Steven Lukes' three-dimensional view of power to explore the 2009 H1N1 pandemic vaccination in Sweden and Denmark - two similar countries that arrived at conflicting vaccination strategies. Drawing on interviews with members of each country's pandemic ste…
The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza
Through an analysis of the FDA's approval of the controversial anti-influenza drug Relenza (zanamivir), we interrogate distinct social scientific theories of pharmaceutical regulation. We investigate why, despite internal negative opinions and an Advisory Committee's non-approval recommendation, the FDA approved Relenza in the late 1990s. Based on a close reading of FDA documents, we show how agency officials guided the manufacturer's analyses an…
Chronic Obstructive Pulmonary Disease in Sweden: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy
Socioeconomic, ethnic and gender disparities in Chronic Obstructive Pulmonary Disease (COPD) risk are well established but no studies have applied multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) within an intersectional framework to study this outcome. We study individuals at the first level of analysis and combinations of multiple social and demographic categorizations (i.e., intersectional strata) at the sec…
The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart disease
Modern medicine is overwhelmed by a plethora of both established risk factors and novel biomarkers for diseases. The majority of this information is expressed by probabilistic measures of association such as the odds ratio (OR) obtained by calculating differences in average "risk" between exposed and unexposed groups. However, recent research demonstrates that even ORs of considerable magnitude are insufficient for assessing the ability of risk f…
Categorical and anti-categorical approaches to US racial/ethnic groupings: Revisiting the National 2009 H1N1 Flu Survey (NHFS)
Intersectionality theory calls for the understanding of race/ethnicity, sex/gender and class as interlinked. Intersectional analysis can contribute to public health both through furthering understanding of power dynamics causing health disparities, and by pointing to heterogeneities within, and overlap between, social groups. The latter places the usefulness of social categories in public health under scrutiny. Drawing on McCall we relate the fir…
An intersectional approach to multilevel analysis of individual heterogeneity (Maih) and discriminatory accuracy
Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches
Intersectionality theory can contribute to epidemiology and public health by furthering understanding of power dynamics driving production of health disparities, and increasing knowledge about heterogeneities within, and overlap between, social categories. Drawing on McCall, we relate the first of these potential contributions to categorical intersectionality and the second to anti-categorical intersectionality. Both approaches are used in study …
Contemporary Epidemiology: A Review of Critical Discussions Within the Discipline and A Call for Further Dialogue with Social Theory
The discipline of epidemiology, which holds major influence on public health policy as well as on clinical medical practice, has in recent decades to a large extent been concerned with the identification of factors and markers of risk for disease. Much health information and intervention is thus informed by a wealth of studies on a variety of risk factors, of which the individual is encouraged to keep informed and to be responsible about. Meanwhi…
Regulating Pharmaceutical Industry Marketing: Development, Enforcement, and Outcome of Marketing Rules
This essay reviews work in sociology and cognate fields regarding pharmaceutical marketing and its regulation. In particular, it considers how this literature contributes to a better understanding of the process of pharmaceuticalization, defined as “the translation or transformation of human conditions, capabilities, and capacities into opportunities for pharmaceutical intervention.” The review addresses two research areas that offer productive a…
Appropriate assessment of ethnic differences in adolescent use of psychotropic medication: Multilevel analysis of discriminatory accuracy
Even though we found associations between MCOB and adolescent use of psychotropic medication, the small ICC and AU-ROC indicate that MCOB appears to be an inaccurate context for discriminating adolescent use of psychotropic medication in Sweden
Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches
Intersectionality theory can contribute to epidemiology and public health by furthering understanding of power dynamics driving production of health disparities, and increasing knowledge about heterogeneities within, and overlap between, social categories. Drawing on McCall, we relate the first of these potential contributions to categorical intersectionality and the second to anti-categorical intersectionality. Both approaches are used in study …
An intersectional approach to multilevel analysis of individual heterogeneity (Maih) and discriminatory accuracy
Is there evidence for the racialization of pharmaceutical regulation? Systematic comparison of new drugs approved over five years in the USA and the EU
Recent decades have seen much interest in racial and ethnic differences in drug response. The most emblematic example is the heart drug BiDil, approved by the US Food and Drug Administration in 2005 for "self-identified blacks." Previous social science research has explored this "racialization of pharmaceutical regulation" in the USA, and discussed its implications for the "pharmaceuticalization of race" in terms of reinforcing certain taxonomic …
Patterns of company misconduct, recidivism, and complaint resolution delays: A temporal analysis of UK pharmaceutical industry self‐regulation within the European context
Interfirm self‐regulation through trade associations is common but its effectiveness is debated and likely varies by time, country, and industry. This study examines self‐regulation of pharmaceutical marketing, characterized by delegation of major regulatory responsibilities to trade associations' self‐regulatory bodies. In addressing critical research gaps, this study first analyzes 1,776 complaints against pharmaceutical companies in the UK ove…
Revisiting the pharmaceuticalisation of pandemic influenza using Lukes' framework of power
The power of social actors to drive or block pharmaceutical uptake has been a concern in sociological debates on pharmaceuticalisation, including in the case of pandemic vaccination. We build on Steven Lukes' three-dimensional view of power to explore the 2009 H1N1 pandemic vaccination in Sweden and Denmark - two similar countries that arrived at conflicting vaccination strategies. Drawing on interviews with members of each country's pandemic ste…
The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza
Through an analysis of the FDA's approval of the controversial anti-influenza drug Relenza (zanamivir), we interrogate distinct social scientific theories of pharmaceutical regulation. We investigate why, despite internal negative opinions and an Advisory Committee's non-approval recommendation, the FDA approved Relenza in the late 1990s. Based on a close reading of FDA documents, we show how agency officials guided the manufacturer's analyses an…
Regulating Pharmaceutical Industry Marketing: Development, Enforcement, and Outcome of Marketing Rules
This essay reviews work in sociology and cognate fields regarding pharmaceutical marketing and its regulation. In particular, it considers how this literature contributes to a better understanding of the process of pharmaceuticalization, defined as “the translation or transformation of human conditions, capabilities, and capacities into opportunities for pharmaceutical intervention.” The review addresses two research areas that offer productive a…
Race in clinical trials in Sweden: How regulatory and medical standards in clinical research trump the post-racial discourse
The post-racial discourse that permeates many Western European countries depicts society as having moved beyond race concepts and classifications. This article focuses on Sweden, a country that, in line with the post-racial thinking, declares race to be an offensive and unscientific concept. The article investigates what happens when this post-racial discourse meets clinical research standards that encourage, if not demand, the collection of data…
Short-circuiting biology: Digital phenotypes, digital biomarkers, and shifting gazes in psychiatry
Digital phenotyping is a rapidly growing research field promising to transform how psychiatry measures, classifies, predicts, and explains human behavior. This article advances the social-scientific examination of digital phenotyping's epistemology and knowledge claims. Drawing on the notion of a "neuromolecular gaze" in psychiatry since the 1960s, it suggests that digital phenotyping concerns a new psychiatric gaze-the "digital gaze." Rather tha…
Pharmaceutical lobbying and pandemic stockpiling: A feeling of déjà vu in the Nordic countries and why the sociological perspective is crucial to understand Covid-19
The novel coronavirus SARS-CoV-2 (COVID-19) has spread globally in a short period of time and quickly developed into a pandemic. In connection with its progress, entire cities and countries have been closed down, people are quarantined, and infrastructure and trade have been suspended. As this is a new virus, no vaccine or antiviral drugs are available, but instead non-medical measures such as social distancing may be used to reduce the spread. T…
Appropriate assessment of ethnic differences in adolescent use of psychotropic medication: Multilevel analysis of discriminatory accuracy
Even though we found associations between MCOB and adolescent use of psychotropic medication, the small ICC and AU-ROC indicate that MCOB appears to be an inaccurate context for discriminating adolescent use of psychotropic medication in Sweden
Divergence and convergence of commercial and scientific priorities in drug development: The case of Zelmid, the first SSRI antidepressant
Based on a realist conceptualization of interests, this paper explores how commercial and scientific priorities appear to have converged and diverged during the development of the antidepressant Zelmid. The drug represents the first of the selective serotonin reuptake inhibitors (SSRIs) to reach the market. Zelmid was synthesized in 1971 and launched by the Swedish firm Astra in 1982, but subsequently withdrawn the next year because of adverse ne…
Regulating drug information in Europe: A Pyrrhic Victory for Pharmaceutical Industry Critics
Informed by recent sociological debates on pharmaceuticalisation, this article examines the evolution of the current EU legal proposal on prescription drug information to patients, as well as the surrounding controversies. In 2008 the European Commission proposed the relaxation of the existing rules governing drug information provision to patients by the pharmaceutical industry. Critics of the industry’s influence over health policy and markets, …
Genetics and democracy—what is the issue
Regulating drug information in Europe: A Pyrrhic Victory for Pharmaceutical Industry Critics
Informed by recent sociological debates on pharmaceuticalisation, this article examines the evolution of the current EU legal proposal on prescription drug information to patients, as well as the surrounding controversies. In 2008 the European Commission proposed the relaxation of the existing rules governing drug information provision to patients by the pharmaceutical industry. Critics of the industry’s influence over health policy and markets, …
Money, Money, Money? Politico-Moral Discourses of Stem Cell Research in a Grant Allocation Process
Concerns have been raised about the marketization of science through the prevailing funding regime. However, the present article will discuss how it comes that the potentially marketable stem cell science is not more commercialized than what is currently the case. We approach this question by analysing discursive pluralism in defining the value of stem cells within a grant allocation process. More specifically, we focus on how the commercial impe…
Divergence and convergence of commercial and scientific priorities in drug development: The case of Zelmid, the first SSRI antidepressant
Based on a realist conceptualization of interests, this paper explores how commercial and scientific priorities appear to have converged and diverged during the development of the antidepressant Zelmid. The drug represents the first of the selective serotonin reuptake inhibitors (SSRIs) to reach the market. Zelmid was synthesized in 1971 and launched by the Swedish firm Astra in 1982, but subsequently withdrawn the next year because of adverse ne…
Contemporary Epidemiology: A Review of Critical Discussions Within the Discipline and A Call for Further Dialogue with Social Theory
The discipline of epidemiology, which holds major influence on public health policy as well as on clinical medical practice, has in recent decades to a large extent been concerned with the identification of factors and markers of risk for disease. Much health information and intervention is thus informed by a wealth of studies on a variety of risk factors, of which the individual is encouraged to keep informed and to be responsible about. Meanwhi…
Regulating Pharmaceutical Industry Marketing: Development, Enforcement, and Outcome of Marketing Rules
This essay reviews work in sociology and cognate fields regarding pharmaceutical marketing and its regulation. In particular, it considers how this literature contributes to a better understanding of the process of pharmaceuticalization, defined as “the translation or transformation of human conditions, capabilities, and capacities into opportunities for pharmaceutical intervention.” The review addresses two research areas that offer productive a…
Appropriate assessment of ethnic differences in adolescent use of psychotropic medication: Multilevel analysis of discriminatory accuracy
Even though we found associations between MCOB and adolescent use of psychotropic medication, the small ICC and AU-ROC indicate that MCOB appears to be an inaccurate context for discriminating adolescent use of psychotropic medication in Sweden
The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart disease
Modern medicine is overwhelmed by a plethora of both established risk factors and novel biomarkers for diseases. The majority of this information is expressed by probabilistic measures of association such as the odds ratio (OR) obtained by calculating differences in average "risk" between exposed and unexposed groups. However, recent research demonstrates that even ORs of considerable magnitude are insufficient for assessing the ability of risk f…
Categorical and anti-categorical approaches to US racial/ethnic groupings: Revisiting the National 2009 H1N1 Flu Survey (NHFS)
Intersectionality theory calls for the understanding of race/ethnicity, sex/gender and class as interlinked. Intersectional analysis can contribute to public health both through furthering understanding of power dynamics causing health disparities, and by pointing to heterogeneities within, and overlap between, social groups. The latter places the usefulness of social categories in public health under scrutiny. Drawing on McCall we relate the fir…
An intersectional approach to multilevel analysis of individual heterogeneity (Maih) and discriminatory accuracy
Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches
Intersectionality theory can contribute to epidemiology and public health by furthering understanding of power dynamics driving production of health disparities, and increasing knowledge about heterogeneities within, and overlap between, social categories. Drawing on McCall, we relate the first of these potential contributions to categorical intersectionality and the second to anti-categorical intersectionality. Both approaches are used in study …
Chronic Obstructive Pulmonary Disease in Sweden: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy
Socioeconomic, ethnic and gender disparities in Chronic Obstructive Pulmonary Disease (COPD) risk are well established but no studies have applied multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) within an intersectional framework to study this outcome. We study individuals at the first level of analysis and combinations of multiple social and demographic categorizations (i.e., intersectional strata) at the sec…
The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza
Through an analysis of the FDA's approval of the controversial anti-influenza drug Relenza (zanamivir), we interrogate distinct social scientific theories of pharmaceutical regulation. We investigate why, despite internal negative opinions and an Advisory Committee's non-approval recommendation, the FDA approved Relenza in the late 1990s. Based on a close reading of FDA documents, we show how agency officials guided the manufacturer's analyses an…
Sociologiska perspektiv på coronakrisen: Fyra sociologer om samhällets reaktion på covid-19
Sociologisk Forskning bad fyra sociologer i Sverige att svara på några korta frågor om coronapandemin och vårt samhälles hantering av den. Deras tidigare forskning har på olika sätt berört olika frågor såsom socialmedicin och medicinsk kunskapsproduktion, sociala nätverks betydelse för smittspridning, samhällets hantering av kriser och risker, genusaspekter av samhällskriser samt dynamiken mellan expertis, politiker och medborgare i beslutsfattan…
Pharmaceutical lobbying and pandemic stockpiling: A feeling of déjà vu in the Nordic countries and why the sociological perspective is crucial to understand Covid-19
The novel coronavirus SARS-CoV-2 (COVID-19) has spread globally in a short period of time and quickly developed into a pandemic. In connection with its progress, entire cities and countries have been closed down, people are quarantined, and infrastructure and trade have been suspended. As this is a new virus, no vaccine or antiviral drugs are available, but instead non-medical measures such as social distancing may be used to reduce the spread. T…
Revisiting the pharmaceuticalisation of pandemic influenza using Lukes' framework of power
The power of social actors to drive or block pharmaceutical uptake has been a concern in sociological debates on pharmaceuticalisation, including in the case of pandemic vaccination. We build on Steven Lukes' three-dimensional view of power to explore the 2009 H1N1 pandemic vaccination in Sweden and Denmark - two similar countries that arrived at conflicting vaccination strategies. Drawing on interviews with members of each country's pandemic ste…
Pharmaceutical industry self-regulation and non-transparency: Country and company level analysis of payments to healthcare professionals in seven European countries
The European pharmaceutical industry uses the alleged efficacy of self-regulation to question the need for transparency laws similar to the US Physician Payment Sunshine Act. We conducted a comparative analysis of 20 large companies' payment disclosures in seven European countries in 2017-2019. The data was extracted as part of eurosfordocs.eu, a novel transparency project that scrapes and integrates publicly available databases and disclosures. …
Sociologisk forskning om covid-19-pandemin: En introduktion
En pandemi är en kris och som sådan en ny situation som präglas av både vetenskapliga och samhälleliga osäkerheter, i vilken vardagslivets invanda rutiner till viss del omkullkastas. Covid-19-pandemin har synliggjort redan etablerade samhällsstrukturer och ojämlikheter men också förvärrat maktrelationer och utsatthet. I denna artikel introducerar vi bidragen i Sociologisk Forsknings temanummer om hur samhället och människors liv har påverkats av …
Is there evidence for the racialization of pharmaceutical regulation? Systematic comparison of new drugs approved over five years in the USA and the EU
Recent decades have seen much interest in racial and ethnic differences in drug response. The most emblematic example is the heart drug BiDil, approved by the US Food and Drug Administration in 2005 for "self-identified blacks." Previous social science research has explored this "racialization of pharmaceutical regulation" in the USA, and discussed its implications for the "pharmaceuticalization of race" in terms of reinforcing certain taxonomic …
Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
Pharmaceutical industry funding of patient organizations raises ethical challenges related to patient engagement in healthcare due to fears of commercial agendas influencing patient advocacy and creating industry-driven inequalities across patient organizations. We contribute to an international body of knowledge on patient organization-industry relations by analyzing all payments reported by companies in Denmark over a six-year period, 2014-2019…
The making of a Swedish strategy: How organizational culture shaped the Public Health Agency's pandemic response
Several suggestions have been made as to why Sweden's approach to managing the COVID-19 pandemic came to rely on a strategy based on voluntary measures. Two of the most prominent explanations for why the country chose a different strategy than many other countries have focused on micro- and macro-level factors, explaining the strategy either in terms of the psychologies of prominent actors or by pointing to particularities in Swedish constitution…
Capitalizing on transparency: Commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act
How corporations surveil and influence consumers using big data tools is a major area of research and public debate. However, few studies explore it in relation to physicians in the USA, even though they have been surveilled and targeted by the pharmaceutical industry since at least the 1950s. Indeed, in 2010, concerns about the pharmaceutical industry's undue influence led to the passing of the Physician Sunshine Act, a unique piece of transpare…
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: Implications for self-regulation, public regulation, and transparency
BACKGROUND: Self-regulation of payment disclosure by pharmaceutical industry trade groups is a major global approach to increasing transparency of financial relationships between drug companies and healthcare professionals and organisations. Nevertheless, little is known about the relative strengths and weaknesses of self-regulation across countries, especially beyond Europe. To address this gap in research and stimulate international policy lear…
Short-circuiting biology: Digital phenotypes, digital biomarkers, and shifting gazes in psychiatry
Digital phenotyping is a rapidly growing research field promising to transform how psychiatry measures, classifies, predicts, and explains human behavior. This article advances the social-scientific examination of digital phenotyping's epistemology and knowledge claims. Drawing on the notion of a "neuromolecular gaze" in psychiatry since the 1960s, it suggests that digital phenotyping concerns a new psychiatric gaze-the "digital gaze." Rather tha…
Conceptual unclarity about Covid-19 ethnic disparities in Sweden: Implications for public health policy
The COVID-19 pandemic has shed light on abundant racial and ethnic health disparities in many countries around the world. In Sweden, statistics on COVID-19 mortality and morbidity from both the first and the second wave of the pandemic show that foreign-born individuals have been disproportionately affected, compared to Swedish-born individuals. However, as demonstrated in this article, key stakeholders including politicians, public authorities, …
Political science (21 works) · Medicine (20 works) · Sociology (18 works) · Law (13 works) · Business (10 works) · Economics (10 works) · Pharmaceutical industry and healthcare (10 works) · Pharmaceutical Economics and Policy (9 works) · Public relations (9 works) · Law (8 works)